BEACON INVESTMENT ADVISORS LLC

Position in JNJ — Johnson & Johnson

CIK 1961635 Gaithersburg, MD

Position in JNJ

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,469,978

+$56,382 QoQ

Shares Held

5,788

+0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

#2,616

of 4,664 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BEACON INVESTMENT ADVISORS LLC holds $4,237,923 across 6 Drug Manufacturers - General names. JNJ ranks #1 (34.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	5,788	$1,469,978
2	AMGN	Amgen Inc	1,847	$668,835
3	MRK	Merck & Co., Inc.	5,120	$657,920
4	BMY	Bristol Myers Squibb Co	10,447	$601,956
5	NVS	Novartis AG	3,000	$470,160
6	PFE	Pfizer Inc	15,327	$369,074

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,469,978	5,788	+0.1%	Shares	Sole	2026-08-13
2026-03-31	$1,413,596	5,783	+0.1%	Shares	Sole	2026-05-14
2025-12-31	$1,195,757	5,778	+0.4%	Shares	Sole	2026-02-17
2025-09-30	$1,067,462	5,757	+0.3%	Shares	Sole	2025-11-14
2025-06-30	$876,785	5,740	+0.1%	Shares	Sole	2025-08-14
2025-03-31	$950,594	5,732	+0.2%	Shares	Sole	2025-05-15
2024-12-31	$827,660	5,723	-2.7%	Shares	Sole	2025-02-14
2024-09-30	$953,561	5,884	+0.1%	Shares	Sole	2024-11-14
2024-06-30	$858,982	5,877	+86.8%	Shares	Sole	2024-08-14
2024-03-31	$497,665	3,146	+0.2%	Shares	Sole	2024-05-13
2023-12-31	$492,006	3,139	+2.3%	Shares	Sole	2024-02-13
2023-09-30	$477,841	3,068	-49.2%	Shares	Sole	2023-11-07
2023-06-30	$998,747	6,034	+7.3%	Shares	Sole	2023-08-03
2023-03-31	$871,565	5,623	-3.8%	Shares	Sole	2023-05-12
2022-12-31	$1,033,049	5,848	—	Shares	Sole	2023-02-09
No filing history on record for this holder in this stock.